This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/519603-vaccine-survey-mutations-covid/

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
Epidemiologists fear Covid-19 mutations could render existing vaccines ineffective in less than 1 year – survey Epidemiologists fear Covid-19 mutations could render existing vaccines ineffective in less than 1 year – survey
(5 months later)
Coronavirus vaccines may become obsolete in less than a year, a new poll conducted among leading epidemiologists suggests. The sloppy vaccination rollouts that have riddled many countries make this scenario even more likely.Coronavirus vaccines may become obsolete in less than a year, a new poll conducted among leading epidemiologists suggests. The sloppy vaccination rollouts that have riddled many countries make this scenario even more likely.
A new survey conducted by the People’s Vaccine Alliance (PVA) among 77 epidemiologists from 28 countries around the world has yielded pessimistic results.A new survey conducted by the People’s Vaccine Alliance (PVA) among 77 epidemiologists from 28 countries around the world has yielded pessimistic results.
Around 66% of those surveyed – including epidemiologists from leading institutions such as Johns Hopkins, Yale, the London School of Hygiene and Tropical Medicine, Imperial College London, and the University of Edinburgh – said Covid-19 could mutate in a year or less to an extent that the first-generation vaccines would become ineffective.Around 66% of those surveyed – including epidemiologists from leading institutions such as Johns Hopkins, Yale, the London School of Hygiene and Tropical Medicine, Imperial College London, and the University of Edinburgh – said Covid-19 could mutate in a year or less to an extent that the first-generation vaccines would become ineffective.
“The more the virus circulates, the more likely it is that mutations and variants will emerge, which could make our current vaccines ineffective,” Devi Sridhar, professor of global public health at the University of Edinburgh, said.“The more the virus circulates, the more likely it is that mutations and variants will emerge, which could make our current vaccines ineffective,” Devi Sridhar, professor of global public health at the University of Edinburgh, said.
“As we’ve learned, viruses don’t care about borders. We have to vaccinate as many people as possible, everywhere in the world, as quickly as possible. Why wait and watch instead of getting ahead of this?”“As we’ve learned, viruses don’t care about borders. We have to vaccinate as many people as possible, everywhere in the world, as quickly as possible. Why wait and watch instead of getting ahead of this?”
The sloppy rollouts and low vaccine coverage that have plagued countries around the world are considered key factors in the potential emergence of vaccine-resistant strains, and 88% of those polled shared this belief.The sloppy rollouts and low vaccine coverage that have plagued countries around the world are considered key factors in the potential emergence of vaccine-resistant strains, and 88% of those polled shared this belief.
Nearly three-quarters of the epidemiologists surveyed said that only an acceleration of the vaccination drives would help. They called for the open sharing of technology and intellectual property, echoing PVA’s own idea of lifting the existing pharmaceutical monopolies to boost the vaccine supply and coverage.Nearly three-quarters of the epidemiologists surveyed said that only an acceleration of the vaccination drives would help. They called for the open sharing of technology and intellectual property, echoing PVA’s own idea of lifting the existing pharmaceutical monopolies to boost the vaccine supply and coverage.
“We all have a self-interest in ensuring that everyone around the world, no matter where they live have access to COVID-19 vaccines. The virus doesn’t respect borders and new variants somewhere on the planet mean none of us are safe,” Gregg Gonsalves, associate professor of epidemiology at Yale University, said.“We all have a self-interest in ensuring that everyone around the world, no matter where they live have access to COVID-19 vaccines. The virus doesn’t respect borders and new variants somewhere on the planet mean none of us are safe,” Gregg Gonsalves, associate professor of epidemiology at Yale University, said.
Think your friends would be interested? Share this story!Think your friends would be interested? Share this story!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.